The Rb protein is a tumour suppressor with an integral role in cell cycle progression, controlling the passage from G1 into S phase (Weinberg, 1995) and ∼90% of patients with a heterozygous germline RB mutation develop childhood onset retinoblastoma. Here, RB1 is linked to retinoblastoma.